{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:40:40Z","timestamp":1767148840771,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/j.yrtph.2014.08.007","type":"addendum","label":"Addendum","source":"publisher","updated":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000}}],"reference-count":7,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,8,12]],"date-time":"2014-08-12T00:00:00Z","timestamp":1407801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.yrtph.2014.08.006","type":"journal-article","created":{"date-parts":[[2014,8,19]],"date-time":"2014-08-19T12:32:52Z","timestamp":1408451572000},"page":"S93-S95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S","title":["Appendix: Alternative Tier 2 health effects testing requirements for gasoline and oxygenated gasolines"],"prefix":"10.1016","volume":"70","member":"78","reference":[{"key":"10.1016\/j.yrtph.2014.08.006_b0005","unstructured":"CFR 79. Chapter I \u2013 Environmental Protection Agency (Continued), Subchapter C \u2013 Air Programs (Continued), Part 79 \u2013 Registration of Fuels and Fuel Additives, Final Rule, 59 Fed. Reg. 33042 (June 27, 1994)."},{"key":"10.1016\/j.yrtph.2014.08.006_b0010","unstructured":"EPA, 1996. Oxyfuels Information Needs, EPA\/600\/R-96\/069 (May 1996) (Docket Item A-96-16\/II-A\/4)."},{"key":"10.1016\/j.yrtph.2014.08.006_b0015","unstructured":"EPA, 1998. Letter to API from EPA dated November 2, 1998. http:\/\/www.epa.gov\/otaq\/fuels\/registrationfuels\/documents\/fnlno19a.pdf."},{"key":"10.1016\/j.yrtph.2014.08.006_b0020","unstructured":"Federal Docket, 2003. These reports can be found in the Federal Docket Management System at www.regulations.gov under the Docket Identification number EPA-HQ-OAR-2003-0065."},{"key":"10.1016\/j.yrtph.2014.08.006_b0025","unstructured":"Health Effects Institute, 1996. Oxygenates Evaluation Committee, The Potential Health Effects of Oxygenates Added to Gasoline, (April 1996). (Docket Item A-96-16\/II-A-2)."},{"key":"10.1016\/j.yrtph.2014.08.006_b0030","unstructured":"National Research Council, 1996. Committee on Toxicological and Performance Aspects of Oxygenated and Reformulated Motor Vehicle Fuels, Toxicological and Performance Aspects of Oxygenated Motor Vehicle Fuels., National Academy Press, Washington, D.C., (June 19, 1996). (Docket Item A-96-16\/II-A-3)."},{"key":"10.1016\/j.yrtph.2014.08.006_b0035","unstructured":"NSTCC, 1997. National Science and Technology Council Committee on Environment and Natural Resources, Interagency Oxygenated Fuels and Assessment Steering Committee, Interagency Assessment of Potential Health Risks Associated with Oxygenated Gasoline, (February 1996-draft, July 1997-final) (hereinafter Interagency Assessment)(Docket Items A-96-16\/II-A-1 & II-A-6). The Interagency Assessment focused on inhalation exposures. The 1997 document specifically stated that \u201cBecause of the very limited data set for oxygenates in drinking water, it is not possible to characterize human exposures from consumption of contaminated drinking water\u201d. Page v \u2013 executive summary."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027323001400186X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027323001400186X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:25:54Z","timestamp":1759494354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027323001400186X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S027323001400186X"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2014.08.006","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Appendix: Alternative Tier 2 health effects testing requirements for gasoline and oxygenated gasolines","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2014.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2014.08.007","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Author. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}